Optometry AHPRA · TGA · ACL Updated 2026

Optometry Advertising Rules Australia 2025 — AHPRA, TGA & ACL Compliance Guide

Australian optometrists operate under a dual regulatory framework: as AHPRA-registered health practitioners subject to the National Law s.133 advertising restrictions, and as retailers of therapeutic goods (contact lenses, certain ophthalmic products) subject to the TGA Advertising Code 2021. This guide covers every major compliance obligation for optometry practices in Australia.

Regulatory Overview

Optometrists are registered under the Optometry Board of Australia (an AHPRA national board). All advertising by or on behalf of a registered optometrist must comply with:

  • Health Practitioner Regulation National Law 2009 s.133 — prohibits false/misleading claims, prohibited testimonials, unreasonable outcome expectations, and encouragement of unnecessary treatment
  • AHPRA Advertising Guidelines (2020, updated 2023) — detailed guidance on testimonials, before/after photos, and social media
  • Optometry Board of Australia Guidelines — profession-specific guidance on scope of practice advertising
  • Therapeutic Goods Advertising Code 2021 — applies to therapeutic medical devices including contact lenses
  • Australian Consumer Law (ACL) — prohibits misleading conduct, false representations, and unfair pricing practices

Key distinction: Optical dispensers are not AHPRA-registered and are not subject to the National Law s.133 testimonial ban — but they are still bound by ACL and TGA rules for any therapeutic products they supply.

Testimonial Ban & Patient Reviews

Under National Law s.133(1)(c), registered optometrists must not use testimonials or endorsements about professional services. This is one of the most commonly misunderstood rules in optometry marketing.

What is prohibited

  • Quoting patient reviews in your own advertising or website
  • Re-sharing Google, Facebook, or Healthengine reviews on your clinic channels
  • Video testimonials from patients about your clinical care
  • Screenshots of positive reviews used in social media posts
  • "What our patients say" sections on clinic websites
❌ Non-compliant
"I can finally see clearly for the first time in years! Dr Smith is incredible." — Sarah M., patient
Breach: Clinical testimonial about professional services (s.133(1)(c))
✅ Compliant
"The staff were friendly and the wait time was short." — Non-clinical review about service experience
AHPRA guidance allows reviews about administrative/service experience (not clinical outcomes). Still — re-sharing this carries compliance risk; seek legal advice.

Third-party review platforms

Google Reviews and similar platforms are not controlled by the practice, so their existence alone is not a breach. However:

  • You must not solicit testimonials about clinical services from patients
  • You must not re-share clinical testimonials on your own channels
  • Responding to reviews is generally acceptable but responses must not amplify clinical claims

2023 AHPRA update: AHPRA clarified that practices cannot provide incentives (e.g. discounts, competition entries) in exchange for patient reviews about clinical services.

TGA Rules for Contact Lenses & Ophthalmic Products

Contact lenses are classified as Class IIa therapeutic medical devices under the Therapeutic Goods Act 1989 and must be listed on the Australian Register of Therapeutic Goods (ARTG). Advertising of these products is regulated by the TGA Advertising Code 2021.

Contact lens advertising — key rules

✅ Permitted

  • Advertising ARTG-listed contact lens brands by name
  • Promoting comfort, wearability, and convenience features
  • Comparing prices between equivalent listed products
  • Advertising availability of daily, fortnightly, monthly lens options
  • Promoting dry-eye compatible lenses (without unsubstantiated medical claims)

❌ Prohibited

  • Claims of disease treatment (e.g. "treats keratoconus")
  • Comparing therapeutic performance without clinical evidence
  • Claiming superiority over other ARTG-listed devices without evidence
  • Using testimonials about therapeutic outcomes for lenses
  • Advertising prescription contact lenses in a way that bypasses practitioner involvement

Ophthalmic drops and supplements

Eye drops and ophthalmic supplements may be scheduled medicines or listed therapeutic goods. The advertising rules depend on classification:

Listed (AUST L)
OTC Eye Drops
Lubricating drops, allergy drops — can be advertised to consumers with approved indications only. No unsubstantiated claims.
Schedule 4
Prescription Eye Drops
Cannot be advertised to consumers. Practitioner-only advertising allowed with strict TGA rules.
Registered (AUST R)
Registered Therapeutics
Higher-evidence products. Consumer advertising restricted to approved indications with mandatory statements.
Cosmetic
Non-therapeutic
Cosmetic lenses (coloured, non-corrective) are still medical devices — cannot make therapeutic claims.

Cosmetic contact lenses: Coloured or decorative contact lenses are Class IIa medical devices. Advertising them as "fashion accessories" without noting they require professional fitting and are therapeutic goods is a TGA compliance risk.

Outcome Claims & Visual Acuity Advertising

National Law s.133(1)(d) prohibits creating an unreasonable expectation of beneficial treatment. Visual outcome claims require particular care.

Visual acuity claims

❌ Non-compliant
"Restore perfect 20/20 vision with our orthokeratology program — guaranteed results in 2 weeks!"
Breach: Outcome guarantee, unreasonable expectation (s.133(1)(d)), and misleading claim (ACL s.18)
✅ Compliant
"Orthokeratology (Ortho-K) lenses can temporarily reduce myopia — individual results vary. A comprehensive eye examination is required to determine suitability."
Qualified, evidence-based claim with appropriate disclaimer and professional consultation requirement

Myopia control advertising

Myopia control is a growing area of optometry marketing. Claims must be:

  • Supported by current clinical evidence (e.g. peer-reviewed studies for Ortho-K, multifocal lenses, atropine)
  • Qualified with individual variation statements
  • Not presented as guaranteed outcomes
  • Not suggesting that delay in treatment will cause identifiable harm (could constitute encouraging unnecessary treatment)

Before/after imagery

AHPRA's 2023 guidelines restrict before/after comparisons. For optometry, this means visual comparisons showing simulated vision with vs. without correction must:

  • Not imply specific outcomes for individual patients
  • Clearly label that images are illustrative/simulated
  • Not use actual patient eye images without careful compliance review

Pricing, Bulk Billing & ACL Obligations

Optometry practices routinely advertise pricing for eye examinations, contact lenses, and spectacles. All pricing claims must comply with ACL.

Medicare bulk billing

❌ Non-compliant
"Bulk billing available for all patients"
Misleading if bulk billing is only available for Medicare-eligible patients for standard consultations, not all services
✅ Compliant
"Standard eye examinations bulk billed for Medicare card holders. Additional fees may apply for contact lens fittings, specialty testing, or extended consultations."
Accurate scope, clear conditions, no hidden fees

Key ACL pricing rules for optometry

  • "Free eye test with purchase" — must honour the offer for all eligible purchases; conditions must be clearly disclosed upfront
  • "From $X frames" — must be a genuine available starting price, not a price only available for severely limited stock
  • Private health insurance claims — must not overstate rebate amounts; actual rebates vary by fund and level of cover
  • Package deals — total cost must be clearly shown; must not use drip pricing that adds lens costs after advertising frame price only
  • Sale pricing — "Was $X, Now $Y" requires the "was" price to have been a genuine price charged for a reasonable period

Social Media Compliance

AHPRA's advertising rules apply to all channels operated by or on behalf of an optometry practice — Instagram, Facebook, TikTok, YouTube, LinkedIn, and practice websites alike.

Common social media compliance issues

  • Re-sharing patient reviews — "We're so touched by this review 💚" posts sharing clinical testimonials breach s.133(1)(c)
  • Influencer promotions — if an influencer promotes your practice or its clinical services, you are responsible for ensuring the content complies with AHPRA rules
  • Before/after reels — simulated vision comparisons or patient outcome videos require careful compliance review
  • Superlative claims — "Best optometrist in [suburb]", "Award-winning eye care" without substantiation breach s.133(1)(a) and ACL
  • Comment sections — if a patient posts a clinical testimonial in your comments, you should remove it or it may constitute your advertising

TikTok / Reels: Short-form video content is increasingly scrutinised by AHPRA. "Eye transformation" videos showing dramatic clinical outcomes are a known area of concern.

Title & Qualification Restrictions

Only AHPRA-registered optometrists may use the protected title "optometrist" in advertising. Using protected titles without valid registration is a criminal offence under the National Law.

Title usage rules

  • Staff who are not optometrists cannot be described as "our optometrists" even informally
  • Optical dispensers must not be described using language that implies optometry registration
  • "Therapeutic optometrist" — valid if the practitioner holds therapeutic endorsement from the Optometry Board; must not be used otherwise
  • "Behavioural optometrist" — acceptable as a descriptor of practice area, not a protected title, but claims about behavioural optometry effectiveness must be evidence-based

Visiting practitioners: If your practice hosts visiting ophthalmologists or orthoptists, advertising must clearly distinguish their role and qualifications from in-house optometrists.

Penalties

Violations can attract penalties from multiple regulators simultaneously.

AHPRA — National Law
$30,000+
Per offence for individuals. Corporations face higher penalties. AHPRA can also investigate and discipline registered practitioners.
TGA — Medical Device
$1.565M
Civil penalty per offence for advertising therapeutic goods (incl. contact lenses) in breach of the Advertising Code.
ACCC — ACL
$50M+
Corporations. For false/misleading representations including pricing claims and unsubstantiated performance claims.
AHPRA — Registration
Suspension
Serious or repeated advertising breaches can result in conditions, suspension, or cancellation of optometry registration.

Optometry Advertising Compliance Checklist

  • No patient testimonials about clinical services used in any advertising channel
  • No re-sharing of patient reviews on practice social media
  • All contact lens brands advertised are ARTG-listed
  • No therapeutic claims for contact lenses beyond approved indications
  • Cosmetic lenses advertised as medical devices requiring professional fitting
  • Visual acuity outcome claims qualified with individual variation statements
  • No guarantee of specific visual outcomes
  • Before/after imagery labelled as illustrative or simulated
  • Bulk billing claims clearly state eligible patient categories
  • "From $X" pricing represents a genuine available price
  • Package pricing shows total cost upfront (no drip pricing)
  • "Free eye test" conditions clearly disclosed
  • Superlative claims ("best", "award-winning") substantiated
  • Only AHPRA-registered optometrists described as "optometrists"
  • Influencer and third-party promotions reviewed for AHPRA compliance
  • Social media comments monitoring process in place

Check Your Optometry Practice Ads for AHPRA & TGA Violations

Paste your eye care ad, contact lens promotion, or practice website — ClearAd flags AHPRA testimonial bans, TGA therapeutic device claims, and ACL pricing issues with specific fix suggestions.

Check My Optometry Ad Free